Exchange Traded Concepts, LLC Monte Rosa Therapeutics, Inc. Transaction History
Exchange Traded Concepts, LLC
- $3.81 Billion
- Q1 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 46,787 shares of GLUE stock, worth $182,001. This represents 0.01% of its overall portfolio holdings.
Number of Shares
46,787
Previous 23,327
100.57%
Holding current value
$182,001
Previous $131,000
151.15%
% of portfolio
0.01%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding GLUE
# of Institutions
71Shares Held
34.5MCall Options Held
80.3KPut Options Held
12.6K-
Nea Management Company, LLC Timonium, MD7.69MShares$29.9 Million3.81% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.1MShares$19.8 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$19.1 Million0.44% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.54MShares$17.6 Million0.39% of portfolio
-
Black Rock Inc. New York, NY2.31MShares$8.97 Million0.0% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $182M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...